|
1
|
Cena H, Chiovato L and Nappi RE: Obesity,
polycystic ovary syndrome, and infertility: A new avenue for GLP-1
receptor agonists. J Clin Endocrinol Metab. 105:e2695–e2709. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goodarzi MO, Dumesic DA, Chazenbalk G and
Azziz R: Polycystic ovary syndrome: Etiology, pathogenesis and
diagnosis. Nat Rev Endocrinol. 7:219–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azziz R, Woods KS, Reyna R, Key TJ,
Knochenhauer ES and Yildiz BO: The prevalence and features of the
polycystic ovary syndrome in an unselected population. J Clin
Endocrinol Metab. 89:2745–2749. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ignatov A and Ortmann O: Endocrine risk
factors of endometrial cancer: Polycystic ovary syndrome, oral
contraceptives, infertility, tamoxifen. Cancers (Basel).
12:17662020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Franks S: Polycystic ovary syndrome. N
Engl J Med. 333:853–861. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Witchel SF, Oberfield SE and Peña AS:
Polycystic ovary syndrome: Pathophysiology, presentation, and
treatment with emphasis on adolescent girls. J Endocr Soc.
3:1545–1573. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Legro RS, Arslanian SA, Ehrmann DA, Hoeger
KM, Murad MH, Pasquali R and Welt CK; Endocrine Society, :
Diagnosis and treatment of polycystic ovary syndrome: An endocrine
society clinical practice guideline. J Clin Endocrinol Metab.
98:4565–4592. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bednarska S and Siejka A: The pathogenesis
and treatment of polycystic ovary syndrome: What's new? Adv Clin
Exp Med. 26:359–367. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eppig JJ: Reproduction: Oocytes call,
granulosa cells connect. Curr Biol. 28:R354–R356. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Das M, Djahanbakhch O, Hacihanefioglu B,
Saridogan E, Ikram M, Ghali L, Raveendran M and Storey A: Granulosa
cell survival and proliferation are altered in polycystic ovary
syndrome. J Clin Endocrinol Metab. 93:881–887. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dumesic DA and Richards JS: Ontogeny of
the ovary in polycystic ovary syndrome. Fertil Steril. 100:23–38.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kondapaneni V, Gutlapalli SD, Poudel S,
Zeb M, Toulassi IA and Cancarevic I: Significance of homocysteine
levels in the management of polycystic ovarian syndrome: A
literature review. Cureus. 12:e111102020.PubMed/NCBI
|
|
13
|
Kelly CJ, Speirs A, Gould GW, Petrie JR,
Lyall H and Connell JM: Altered vascular function in young women
with polycystic ovary syndrome. J Clin Endocrinol Metab.
87:742–746. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Legro RS, Kunselman AR and Dunaif A:
Prevalence and predictors of dyslipidemia in women with polycystic
ovary syndrome. Am J Med. 111:607–613. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv Q, Niu H, Yue L, Liu J, Yang L, Liu C,
Jiang H, Dong S, Shao Z, Xing L and Wang H: Abnormal ferroptosis in
myelodysplastic syndrome. Front Oncol. 10:16562020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang L, Wang F, Li D, Yan Y and Wang H:
Transferrin receptor-mediated reactive oxygen species promotes
ferroptosis of KGN cells via regulating NADPH oxidase 1/PTEN
induced kinase 1/acyl-CoA synthetase long chain family member 4
signaling. Bioengineered. 12:4983–4994. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Huang Z, Xie Z, Chen Y, Zheng Z,
Wei X, Huang B, Shan Z, Liu J, Fan S, et al: Homocysteine induces
oxidative stress and ferroptosis of nucleus pulposus via enhancing
methylation of GPX4. Free Radic Biol Med. 160:552–565. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Collignon E, Canale A, Al Wardi C, Bizet
M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W,
Wilson A, et al: Immunity drives TET1 regulation in cancer through
NF-κB. Sci Adv. 4:eaap73092018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kabiraj P, Valenzuela CA, Marin JE,
Ramirez DA, Mendez L, Hwang MS, Varela-Ramirez A, Fenelon K,
Narayan M and Skouta R: The neuroprotective role of ferrostatin-1
under rotenone-induced oxidative stress in dopaminergic
neuroblastoma cells. Protein J. 34:349–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng F, Sharma I, Dai Y, Yang M and Kanwar
YS: Myo-inositol oxygenase expression profile modulates pathogenic
ferroptosis in the renal proximal tubule. J Clin Invest.
129:5033–5049. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu B, Liu Y, Chen X, Zhao J, Han J, Dong
H, Zheng Q and Nie G: Ferrostatin-1 protects auditory hair cells
from cisplatin-induced ototoxicity in vitro and in vivo. Biochem
Biophys Res Commun. 533:1442–1448. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu L, Jia F, Wei J, Yu Y, Yu T, Wang Y,
Sun J and Luo G: Salidroside protects against homocysteine-induced
injury in human umbilical vein endothelial cells via the regulation
of endoplasmic reticulum stress. Cardiovasc Ther. 35:33–39. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ajmal N, Khan SZ and Shaikh R: Polycystic
ovary syndrome (PCOS) and genetic predisposition: A review article.
Eur J Obstet Gynecol Reprod Biol X. 3:1000602019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Knochenhauer ES, Key TJ, Kahsar-Miller M,
Waggoner W, Boots LR and Azziz R: Prevalence of the polycystic
ovary syndrome in unselected black and white women of the
southeastern United States: A prospective study. J Clin Endocrinol
Metab. 83:3078–3082. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He M, Mao G, Xiang Y, Li P, Wu Y, Zhao D
and Li T: MicroRNA-664a-3p inhibits the proliferation of ovarian
granulosa cells in polycystic ovary syndrome and promotes apoptosis
by targeting BCL2A1. Ann Transl Med. 9:8522021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Wang H, Zhou D, Shuang T, Zhao H and
Chen B: Up-regulation of long noncoding RNA SRA promotes cell
growth, inhibits cell apoptosis, and induces secretion of estradiol
and progesterone in ovarian granular cells of mice. Med Sci Monit.
24:2384–2390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Zheng Q, Sun D, Cui X, Chen S,
Bulbul A, Liu S and Yan Q: Dehydroepiandrosterone stimulates
inflammation and impairs ovarian functions of polycystic ovary
syndrome. J Cell Physiol. 234:7435–7447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu G, Xia J, Yang Z, Chen Y, Jiang W, Yin
T and Yang J: CircASPH promotes KGN cells proliferation through
miR-375/MAP2K6 axis in polycystic ovary syndrome. J Cell Mol Med.
Dec 28–2020.(Epub ahead of print). View Article : Google Scholar
|
|
32
|
Zheng Q, Li Y, Zhang D, Cui X, Dai K, Yang
Y, Liu S, Tan J and Yan Q: ANP promotes proliferation and inhibits
apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex
and improves ovary functions of PCOS rats. Cell Death Dis.
8:e31452017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim JW, Kang KM, Yoon TK, Shim SH and Lee
WS: Study of circulating hepcidin in association with iron excess,
metabolic syndrome, and BMP-6 expression in granulosa cells in
women with polycystic ovary syndrome. Fertil Steril.
102:548–554.e2. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu J, Xiong Y, Zhang Y, Wen J, Cai N,
Cheng K, Liang H and Zhang W: The molecular mechanisms of
regulating oxidative stress-induced ferroptosis and therapeutic
strategy in tumors. Oxid Med Cell Longev. 2020:88107852020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Do Van B, Gouel F, Jonneaux A, Timmerman
K, Gelé P, Pétrault M, Bastide M, Laloux C, Moreau C, Bordet R, et
al: Ferroptosis, a newly characterized form of cell death in
Parkinson's disease that is regulated by PKC. Neurobiol Dis.
94:169–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Peng X, Zhang M, Jia Y, Yu B and
Tian J: Revisiting tumors and the cardiovascular system:
Mechanistic intersections and divergences in ferroptosis. Oxid Med
Cell Longev. 2020:97381432020.PubMed/NCBI
|
|
38
|
Li D, Jiang C, Mei G, Zhao Y, Chen L, Liu
J, Tang Y, Gao C and Yao P: Quercetin alleviates ferroptosis of
pancreatic β cells in type 2 diabetes. Nutrients. 12:29542020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song Q, Peng S, Sun Z, Heng X and Zhu X:
Temozolomide drives ferroptosis via a DMT1-dependent pathway in
glioblastoma cells. Yonsei Med J. 62:843–849. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xue X, Ramakrishnan SK, Weisz K, Triner D,
Xie L, Attili D, Pant A, Győrffy B, Zhan M, Carter-Su C, et al:
Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling
to promote colorectal tumorigenesis. Cell Metab. 24:447–461. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao P, Yang W, Wang P, Li X and Nashun B:
Characterization of DNA methylation and screening of epigenetic
markers in polycystic ovary syndrome. Front Cell Dev Biol.
9:6648432021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pan JX, Tan YJ, Wang FF, Hou NN, Xiang YQ,
Zhang JY, Liu Y, Qu F, Meng Q, Xu J, et al: Aberrant expression and
DNA methylation of lipid metabolism genes in PCOS: A new insight
into its pathogenesis. Clin Epigenetics. 10:62018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sagvekar P, Kumar P, Mangoli V, Desai S
and Mukherjee S: DNA methylome profiling of granulosa cells reveals
altered methylation in genes regulating vital ovarian functions in
polycystic ovary syndrome. Clin Epigenetics. 11:612019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Poole CJ, Lodh A, Choi JH and van Riggelen
J: MYC deregulates TET1 and TET2 expression to control global DNA
(hydroxy)methylation and gene expression to maintain a neoplastic
phenotype in T-ALL. Epigenetics Chromatin. 12:412019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chua GNL, Wassarman KL, Sun H, Alp JA,
Jarczyk EI, Kuzio NJ, Bennett MJ, Malachowsky BG, Kruse M and
Kennedy AJ: Cytosine-based TET enzyme inhibitors. ACS Med Chem
Lett. 10:180–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
